Switching HIV therapies: competing host and viral factors

Lancet. 2010 Jan 30;375(9712):352-4. doi: 10.1016/S0140-6736(10)60067-0. Epub 2010 Jan 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1
  • Humans
  • Treatment Outcome
  • Viral Load / drug effects

Substances

  • HIV Protease Inhibitors